Status: current, Primitive. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764507011 | Caplacizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3764508018 | Caplacizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Caplacizumab | Has disposition | Platelet aggregation inhibitor | true | Inferred relationship | Some | ||
| Caplacizumab | Is a | Platelet aggregation inhibitor | true | Inferred relationship | Some | ||
| Caplacizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Caplacizumab-containing product | Has active ingredient | True | Caplacizumab | Inferred relationship | Some | 1 |
| Caplacizumab only product | Has active ingredient | True | Caplacizumab | Inferred relationship | Some | 1 |
| Caplacizumab-containing product in parenteral dose form | Has active ingredient | True | Caplacizumab | Inferred relationship | Some | 1 |
| Caplacizumab only product in parenteral dose form | Has active ingredient | True | Caplacizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR